AT547102T
Carboline derivatives useful in the treatment of cancer
Abstract
According to the present invention, the Calvo phosphorus compound controlled after transferring VEGF revelation and its use were clarified. A useful compound is offered when reducing a useful compound, a compound useful for the medical treatment of solid tumor cancer and plasma, and/or the VEGF level in a tumor by control of VEGF production in one mode of the present invention. Use of this invention compound for reducing plasma and/or the VEGF level in a tumor, in order to treat the cancer for controlling VEGF production in another mode of the present invention is offered.
Term
Term ended
Expired 17 April 2026, 0.4 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
2 priority claims, no other members on record
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 10778305 | United States of America | A | |
| 2006014547 | United States of America | W |
Numbers
- Application
- 6750554
Titles2
- German
- CARBOLIN-DERIVATE ZUR BEHANDLUNG VON KREBS
- English
- CARBOLIN DERIVATIVES FOR THE TREATMENT OF CANCER
Classification
- CPC, 14
- A61K31/337
- A61K31/4353
- A61K31/437
- A61K31/444
- A61K31/497
- A61K31/506
- A61K31/513
- A61K31/5377
- A61K31/541
- A61K31/5513
- G01N2333/475
- A61P9/00
- G01N2333/515
- A61P35/00
- IPC, 10
- A61K31 337
- A61K31 437
- A61K31 444
- A61K31 4745
- A61K31 497
- A61K31 506
- A61K31 5377
- A61K31 541
- A61K31 5513
- A61K31 724